About Me

I, Tanushree Phadke, am a seasoned life sciences professional with over two decades of experience in research, program management, and strategic operations. My journey has spanned small Biotech and Large Pharma in Boston, Massachusetts, U.S., and now extends to Singapore, where I’ve founded BioVertex Consulting LLP to help companies navigate the complexities of drug development and healthcare innovation globally.

My academic foundation includes a Master of Science in Biotechnology from Northeastern University, Boston, MA (USA) and a Bachelor of Engineering in Biomedical from Mumbai University (India), where I graduated with distinction (summa cum laude). I have also pursued advanced genomics, epigenetics, cancer biology, and genome editing coursework at Harvard Extension School. Additionally, I hold a Project Management Professional (PMP) certification, along with training in Biotechnology Project Management, Drug Development, High-Performing Teams, and GenAI.

I’ve successfully led cross-functional teams, advanced preclinical and early-stage clinical cell and gene therapy programs for rare diseases at companies like Tessera Therapeutics and Editas Medicine, and implemented fit-for-purpose portfolio and program management frameworks throughout my career.

At BioVertex Consulting, we bring a tailored, hands-on approach with a curated team of experienced consultants to help clients optimize R&D execution, streamline portfolio management, and enhance operational efficiency. We aim to bridge the gap between scientific innovation and business execution—ensuring life sciences ventures achieve their milestones effectively and efficiently.

Let’s collaborate to accelerate your programs and bring groundbreaking solutions to patients worldwide.

Connect with Tanushree on LinkedIn

External Consultants

"We collaborate with an experienced medical writer holding a PhD from Johns Hopkins and over 17 years of industry experience. This expert has supported biotech clients from IND through NDA/BLA across multiple therapeutic areas including anesthesia, CNS, immunology, oncology, pulmonary diseases, and rheumatology. Their expertise spans a wide range of regulatory documentation, including protocols, investigator brochures, clinical study reports, safety narratives, ISE/ISS/ISI, clinical overviews and summaries (2.7.1, 2.7.2), and briefing documents."

"We partner with a distinguished immunologist whose career spans academia and industry. Holding a PhD in immunology and having completed a postdoctoral fellowship at Harvard Medical School, they bring over a decade of biotech experience in the United States. This expert has guided companies from discovery through IND, shaping programs in autoimmune disease, immunology, and oncology. Their deep expertise in translational and preclinical sciences includes target validation, mechanism-of-action studies, non-clinical development, and patient enrichment strategies. Grounded in scientific rigor and strategic insight, they are dedicated to bridging early innovation with clinical impact."